Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.
To calculate this value, GuruFocus follows these steps:
We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.
GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.
Beijing Balance Medical Technology Co (SHSE:688198) GF Value Explanation
Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:
(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.
(2) A sufficient margin of safety exists only when the stock is undervalued.
Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.
Indicators that a company may be a value trap include:
* Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score. * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials. * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.
Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.
Beijing Balance Medical Technology Co's Price-to-GF-Value for today is calculated as
Price-to-GF-Value
=
Share Price
/
GF Value
=
77.60
/
185.38
=
0.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Balance Medical Technology Co GF Value Related Terms
Beijing Balance Medical Technology Co (SHSE:688198) has a GF Value of ¥185.38 as of Jul. 26, 2026. GF Value represents the current intrinsic value of a stock derived from our exclusive method. View historical data on Beijing Balance Medical Technology Co and its competitors.
Is Beijing Balance Medical Technology Co's GF Value too high?
Beijing Balance Medical Technology Co's current GF Value is ¥185.38. Overall, Beijing Balance Medical Technology Co has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Balance Medical Technology Co's GF Value compare to ABT and SYK?
Beijing Balance Medical Technology Co's GF Value of ¥185.38 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value for a Medical Devices & Instruments company?
A good GF Value depends on the Medical Devices & Instruments industry context. However, GF Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value mean?
A high GF Value can signal that a stock is expensive relative to its fundamentals. GF Value represents the current intrinsic value of a stock derived from our exclusive method. View historical data on Beijing Balance Medical Technology Co and its competitors. Beijing Balance Medical Technology Co's current GF Value is ¥185.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Balance Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co (SHSE:688198) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥185.38, compared to a current price of ¥77.60 — trading 58.1% below its estimated fair value. The current GF Value is ¥185.38. Beijing Balance Medical Technology Co's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value calculated?
GF Value is calculated from a company's financial statements. For Beijing Balance Medical Technology Co (SHSE:688198), the current GF Value is ¥185.38 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Balance Medical Technology Co (SHSE:688198) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co stock appears to be undervalued.
The current stock price of ¥77.60 is trading 58.1% below its estimated GF Value™ of ¥185.38.
GuruFocus considers Beijing Balance Medical Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688198:
GF Value: ¥185.38
GF Value™: ¥185.38 vs. price of ¥77.60 (58.1% below fair value)
No single metric tells the full story. See the SHSE:688198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Balance Medical Technology Co Business Description
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
87GF Score
Get the complete analysis for SHSE:688198
GF Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688198 has been successfully added to your 
